Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Releases.
Press releases published on July 2, 2025
Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy
GlobeNewswire
·
July 2, 2025
TAIPEI, Taiwan, July 02, 2025 (GLOBE NEWSWIRE) -- Primo Biotechnology Co., Ltd., a pioneering radiopharmaceutical company in Taiwan, announced the successful completion of its NT$220 million Series A funding round. With total capital raised now exceeding …
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
GlobeNewswire
·
July 2, 2025
OCALA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a presentation and discussion on immunotherapies involving AIM’s drug Ampligen at the recent U.S.-Poland Science and Technology …
The International Myeloma Foundation Proudly Announces EMA-CHMP Positive Qualification Advice to i2TEAMM Novel Biomarker Procedure Application on the Use of MRDnegCR as an Intermediate Early Endpoint for Conditional Market Approval in Myeloma Clinical…
GlobeNewswire
·
July 2, 2025
STUDIO CITY, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and the collaborative stakeholder group i2TEAMM (International Independent Team for Endpoint Approval of Myeloma MRD), which includes top global myeloma …
AMN Healthcare Sells Smart Square Scheduling Technology to symplr, Creates Commercial Partnership to Deliver Comprehensive Healthcare Workforce Solutions
GlobeNewswire
·
July 2, 2025
DALLAS, July 02, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader in total healthcare talent solutions, today announced the sale of its Smart Square® scheduling software to symplr®, a leader in enterprise healthcare operations software. In …
Cronos Grows its International Footprint in Switzerland
GlobeNewswire
·
July 2, 2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its …
Nuwellis Appoints John Erb as Chief Executive Officer
GlobeNewswire
·
July 2, 2025
WHO WHAT WHERE WHEN HOW John Erb Appointed as Chief Executive Officer (no longer serving in an interim capacity) Nuwellis Headquarters Effective June 27, 2025 Appointment confirmed by the Board of Directors following his interim leadership MINNEAPOLIS, …
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
GlobeNewswire
·
July 2, 2025
PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods® IBS inFoods® IBS provides personalized identification of food …
Extendicare Acquires Closing the Gap Healthcare Group
GlobeNewswire
·
July 2, 2025
MARKHAM, Ontario, July 02, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that its wholly owned home healthcare subsidiary, ParaMed Inc. (“ParaMed” or the “Purchaser”), completed the previously …
IUI Launches Proven Methodology Connecting EIM Strategy and Data Stewardship
EIN Presswire
·
July 2, 2025
IUI formalizes its methodology aligning information strategy with business-driven data stewardship to enhance data governance, quality, and decisions. WASHINGTON, DC, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- Information Unlimited Inc. (IUI), a …
Medical Supplierz Introduces Simplified B2B Platform for Laboratory Equipment Trade
EIN Presswire
·
July 2, 2025
KUWAIT, KUWAIT, July 2, 2025 /EINPresswire.com/ -- Medical Supplierz has launched a dedicated feature within its B2B healthcare marketplace to support seamless buying and selling of laboratory equipment. This development addresses long-standing …
NIFA is proud to announce the promotion of Jim Stobinski to Director of Hospital & ASC Surgical Education Relationships
EIN Presswire
·
July 2, 2025
This senior leadership role is responsible for developing, managing, and sustaining strategic partnerships with hospitals and ambulatory surgery centers (ASCs). CENTENNIAL, CO, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- The National Institute of …
Pneumagen Announces Peer-Reviewed Publication of Positive Phase II Study Data Highlighting the Potential of Neumifil, a Novel Broad-Spectrum Antiviral
GlobeNewswire
·
July 2, 2025
Pneumagen’s intranasal broad-spectrum antiviral therapy reduced infection, improved symptoms and severity and reduced viral load in a Phase II influenza study in data published in the high-impact, peer-reviewed Infectious Diseases and Therapy journal. St …
AppleGate Recovery Unveils Brand Refresh Aligned with BayMark Health Services Continuum of Care
GlobeNewswire
·
July 2, 2025
LEWISVILLE, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- AppleGate Recovery, a leading provider of office-based medication-assisted treatment (MAT) for substance use disorders, is proud to announce the launch of its refreshed brand identity. The update unifies …
Middlesex Recovery Unveils Brand Refresh to Reflect Unified Identity with BayMark Health Services
GlobeNewswire
·
July 2, 2025
LEWISVILLE, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- Middlesex Recovery, a provider of office-based opioid treatment for substance use disorders, has introduced a brand refresh that reflects its alignment with BayMark Health Services and its family of …
PharmaTher Announces Path to Ketamine Commercialization with No Planned Financing, Confirms FDA Approval Goal Date of August 9th, 2025 for Ketamine
GlobeNewswire
·
July 2, 2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on the development and commercialization of ketamine-based pharmaceuticals, is …
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.
GlobeNewswire
·
July 2, 2025
Name change reflects company’s leadership position with its cryptocurrency treasury reserve strategy focused on the HYPE token Company to commence trading on Nasdaq under the symbol “HYPD” effective July 3rd Also announces official launch of the Kinetiq x …
VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202
GlobeNewswire
·
July 2, 2025
BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune- …
BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven
GlobeNewswire
·
July 2, 2025
Together, Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven add 30 satellite locations to enroll patients in BriaCell’s pivotal Phase 3 study BriaCell’s Phase 3 study currently has 58 active clinical sites across 15 states, including …
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
GlobeNewswire
·
July 2, 2025
CLEVELAND, July 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $155 million on June 27, 2025. Including net …
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025
GlobeNewswire
·
July 2, 2025
IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second quarter 2025 financial results after …